Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Critical Reviews in Oral Biology & Medicine
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sugerman, P.B.
Right arrow Articles by Bigby, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

THE PATHOGENESIS OF ORAL LICHEN PLANUS

P.B. Sugerman1,*, N.W. Savage2, L.J. Walsh2, Z.Z. Zhao2, X.J. Zhou2, A. Khan2, G.J. Seymour2 and M. Bigby3

1 AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA;
2 Oral Biology and Pathology, The University of Queensland, St Lucia, Brisbane, Queensland, Australia,
3 Department of Dermatology, Beth Israel Deaconess Medical Center, Brookline, MA, USA


Figure 1
View larger version (32K):
[in this window]
[in a new window]

 
Figure 1. Hypothesis for antigen presentation and T-cell activation in OLP. Initially, the CD8+ T-cell antigen receptor engages a specific foreign antigen (Ag 1) in the context of MHC class I on the basal keratinocyte target cell in OLP [1]. The CD8+ T-cell may then seek CD4+ T-cell confirmation by expressing the hypothetical "request cytotoxic activity" (RCA) cell surface molecule [2]. The CD4+ T-cell expresses the hypothetical "RCA receptor" (RCA R) [4], but only following CD4+ T-cell antigen receptor engagement of a related foreign antigen (Ag 2) in the context of MHC class II on the antigen-presenting cell (basal keratinocyte or Langerhans cell in OLP) [3]. Ligation between RCA and RCA R in combination with co-stimulatory signals from the MHC class II+ antigen-presenting cell (e.g., CD40, CD80, and IL-12 binding CD154, CD28, and IL-12 R, respectively, on the CD4+ T-cell) initiates Th1 differentiation of the CD4+ T-cell that then secretes IL-2 and IFN-{gamma} [5]. Receptors for IL-2 and IFN-{gamma} are expressed by the CD8+ T-cell, but only following (i) specific engagement of the CD8+ T-cell antigen receptor in the context of MHC class I and/or (ii) ligation between RCA and RCA R. The CD4+ Th1 cytokines (IL-2 and IFN-{gamma}) are detected by the CD8+ T-cell and interpreted as confirmation to proceed with target cell (basal keratinocyte) lysis. Keratinocyte activation by (i) the CD4+ or CD8+ T-cell following receptor-antigen-MHC trimerization or (ii) exogenous agents such as viral infection, bacterial products, mechanical trauma, systemic drugs, or contact sensitivity up-regulates keratinocyte cytokine and chemokine secretion [6] that promotes lymphocyte extravasation and directs lymphocyte migration into the site of the developing OLP lesion.

 

Figure 2
Figure 2
View larger version (43K):
[in this window]
[in a new window]

 
Figure 2. Unifying hypothesis for the pathogenesis of OLP. (A) A lichen planus antigen is expressed in association with MHC class I molecules on basal keratinocytes at the OLP lesion site [1]. Antigen-specific CD8+ cytotoxic T-lymphocytes (CTLs) are activated in the OLP epithelium (possibly with help from Th1 CD4+ T-cells, as shown in Fig. 1Go) and trigger keratinocyte apoptosis via secreted TNF-{alpha} binding the TNF-{alpha} receptor (TNF-R1) [2], although roles for granzyme B and Fas cannot be excluded at this stage. TNF-{alpha} may be activated and released from the CTL surface by lesional MMPs. (B) Activated T-cells undergo intra-lesional clonal expansion and release RANTES and other cytokines [3] that up-regulate mast cell CCR1 expression and stimulate intra-lesional mast cell migration and degranulation [4]. Degranulating mast cells release TNF-{alpha}, which up-regulates endothelial cell adhesion molecule expression for lymphocyte adhesion and extravasation [5]. Mast cell TNF-{alpha} also up-regulates RANTES [6] and MMP-9 [7] secretion by OLP lesional T-cells. Activated lesional T-cells (and possibly keratinocytes) secrete chemokines that attract extravasated lymphocytes toward the OLP epithelium [8]. Degranulating mast cells release chymase that damages the epithelial basement membrane directly [9] or indirectly via activation of MMP-9 secreted by OLP lesional T-cells [10]. Epithelial basement membrane disruption facilitates the passage of lymphocytes into the OLP epithelium [11] and denies keratinocytes a cell survival signal, resulting in further keratinocyte apoptosis [12]. (A) Represents the boxed area in (B).

 

Critical Reviews in Oral Biology & Medicine, Vol. 13, No. 4, 350-365 (2002)
DOI: 10.1177/154411130201300405


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?